RxDoctor Payments Data

Gregory Kelley, DO

Family Medicine · Choctaw, OKNPI 1043256019

Payments from drug & device makers

$290in general payments, 2019–2025

Across 30 payments — averaging $9.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amarin Pharma, Inc.$166
  • AbbVie$45
  • AstraZeneca$22
  • Kaleo, Inc.$20
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$13
  • Kowa Pharmaceuticals America, Inc.$12
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$290100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$290 in reported general payments places this provider in the 45th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$130,143
Medicare patients
286
Services billed
3,956

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide81$102,211
FarxigaDapagliflozin Propanediol59$66,069
JanuviaSitagliptin Phosphate64$62,993
JardianceEmpagliflozin36$29,412
EliquisApixaban36$27,555
MounjaroTirzepatide15$18,935
Breo ElliptaFluticasone/Vilanterol17$9,170
InvokanaCanagliflozin12$6,990
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen195$4,942
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide76$4,431
Rosuvastatin Calcium210$3,179
Epinephrine13$2,791
Atorvastatin Calcium245$2,640
FenofibrateFenofibrate Nanocrystallized108$2,589
Gabapentin154$2,391

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$22$66,06959 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Choctaw

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →